Impact of omitting clinical target volume in radiotherapy for locally advanced non-small cell lung cancer: a propensity score matching analysis

Background: Determining the planned target volume (PTV) for locally advanced (LA) non-small cell lung cancer (NSCLC) is often a challenging task for radiation oncologists. Due to advances in effective multidisciplinary treatments, the necessity to reconcile the clinical target volume (CTV) with the...

Full description

Saved in:
Bibliographic Details
Main Authors: Liu, Liang (Author) , Bao, Wen (Author) , Yuan, Xiaoshuai (Author) , Zhu, Yaoyao (Author) , Zhang, Ying (Author) , Christopoulos, Petros (Author) , Abbar, Baptiste (Author) , Qian, Cheng (Author) , Yang, Shuangyan (Author) , Xu, Yaping (Author)
Format: Article (Journal)
Language:English
Published: May 30, 2025
In: Translational Lung Cancer Research
Year: 2025, Volume: 14, Issue: 5, Pages: 1770-1785
ISSN:2226-4477
DOI:10.21037/tlcr-2025-409
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.21037/tlcr-2025-409
Verlag, kostenfrei, Volltext: https://tlcr.amegroups.org/article/view/100778
Get full text
Author Notes:Liang Liu, Wen Bao, Xiaoshuai Yuan, Yaoyao Zhu, Ying Zhang, Petros Christopoulos, Baptiste Abbar, Cheng Qian, Shuangyan Yang, Yaping Xu

MARC

LEADER 00000naa a2200000 c 4500
001 1943020205
003 DE-627
005 20251201123423.0
007 cr uuu---uuuuu
008 251201s2025 xx |||||o 00| ||eng c
024 7 |a 10.21037/tlcr-2025-409  |2 doi 
035 |a (DE-627)1943020205 
035 |a (DE-599)KXP1943020205 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Liu, Liang  |e VerfasserIn  |0 (DE-588)1383122644  |0 (DE-627)1943021767  |4 aut 
245 1 0 |a Impact of omitting clinical target volume in radiotherapy for locally advanced non-small cell lung cancer  |b a propensity score matching analysis  |c Liang Liu, Wen Bao, Xiaoshuai Yuan, Yaoyao Zhu, Ying Zhang, Petros Christopoulos, Baptiste Abbar, Cheng Qian, Shuangyan Yang, Yaping Xu 
264 1 |c May 30, 2025 
300 |b Illustrationen 
300 |a 16 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online erschienen: 28.05.2025 
500 |a Gesehen am 01.12.2025 
520 |a Background: Determining the planned target volume (PTV) for locally advanced (LA) non-small cell lung cancer (NSCLC) is often a challenging task for radiation oncologists. Due to advances in effective multidisciplinary treatments, the necessity to reconcile the clinical target volume (CTV) with the gross tumor volume (GTV) and the PTV presents an ongoing controversy. This study sought to analyze the effects of omitting the CTV on the clinical outcomes of patients with LA-NSCLC. - Methods: Data were retrospectively collected from all consecutive patients with histologically confirmed LA-NSCLC treated with intensity-modulated radiotherapy (IMRT) at Shanghai Pulmonary Hospital from January 2019 to December 2020. The patients were divided into two groups based on different radiotherapy planning techniques: (I) the planning target volume-gross target (PTV-G) group; and (II) the planning target volume-clinical target (PTV-C) group. The PTV-G was directly based on the GTV, while the PTV-C was based on the simulated CTV. A propensity score matching (PSM) analysis was conducted to enhance the comparability of the clinical data between the two groups. The primary endpoint of the study was the occurrence of radiotherapy-associated adverse events. Secondary endpoints included progression-free survival (PFS), overall survival (OS), post-treatment tumor recurrence patterns, and variations in peripheral blood cell characteristics pre- and post-radiotherapy. - Results: A total of 255 patients were identified from our local database. After matching on propensity score with a 1:2 ratio, 156 patients were included in the final analysis, with 52 in the PTV-G group and 104 in the PTV-C group. The incidence of ≥ grade 3 radiation pneumonitis (RP) was significantly higher in the PTV-C group than in the PTV-G group (12.5% vs. 5.7%, P=0.03). Similarly, the incidence of ≥ grade 3 radiation esophagitis was higher in the PTV-C group than the PTV-G group (15.4% vs. 3.8%, P=0.02). However, no statistically significant differences were found between the PTV-G and PTV-C groups in terms of the objective response rate (ORR) and the disease control rate (DCR) (1-year ORR: 57.7% vs. 55.8%, P=0.37; 1-year DCR: 78.8% vs. 84.6%, P=0.16). No differences were found in median PFS (15.4 months for PTV-G vs. 14.8 months for PTV-C, P=0.28) or median OS (26.8 months for PTV-G vs. 25.4 months for PTV-C, P=0.06). - Conclusions: Omitting the CTV was associated with a decrease of grade ≥3 radiation-induced toxicities without pejorative impact on PFS or OS in LA-NSCLC patients treated with IMRT. Furthermore, no increase in regional or metastatic recurrence rates were observed. This radiotherapy strategy may be a viable option for selected LA-NSCLC patients, reducing toxicities without compromising outcomes. 
700 1 |a Bao, Wen  |e VerfasserIn  |4 aut 
700 1 |a Yuan, Xiaoshuai  |e VerfasserIn  |4 aut 
700 1 |a Zhu, Yaoyao  |e VerfasserIn  |4 aut 
700 1 |a Zhang, Ying  |e VerfasserIn  |4 aut 
700 1 |a Christopoulos, Petros  |d 1977-  |e VerfasserIn  |0 (DE-588)138659702  |0 (DE-627)604886756  |0 (DE-576)308488067  |4 aut 
700 1 |a Abbar, Baptiste  |e VerfasserIn  |4 aut 
700 1 |a Qian, Cheng  |e VerfasserIn  |4 aut 
700 1 |a Yang, Shuangyan  |e VerfasserIn  |4 aut 
700 1 |a Xu, Yaping  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Translational Lung Cancer Research  |d [Erscheinungsort nicht ermittelbar] : [Verlag nicht ermittelbar], 2012  |g 14(2025), 5 vom: Mai, Seite 1770-1785  |h Online-Ressource  |w (DE-627)777778599  |w (DE-600)2754335-3  |w (DE-576)400525224  |x 2226-4477  |7 nnas  |a Impact of omitting clinical target volume in radiotherapy for locally advanced non-small cell lung cancer a propensity score matching analysis 
773 1 8 |g volume:14  |g year:2025  |g number:5  |g month:05  |g pages:1770-1785  |g extent:16  |a Impact of omitting clinical target volume in radiotherapy for locally advanced non-small cell lung cancer a propensity score matching analysis 
856 4 0 |u https://doi.org/10.21037/tlcr-2025-409  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://tlcr.amegroups.org/article/view/100778  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20251201 
993 |a Article 
994 |a 2025 
998 |g 138659702  |a Christopoulos, Petros  |m 138659702:Christopoulos, Petros  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PC138659702  |e 950000PC138659702  |e 950900PC138659702  |e 50000PC138659702  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 6 
999 |a KXP-PPN1943020205  |e 4818208221 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"doi":["10.21037/tlcr-2025-409"],"eki":["1943020205"]},"language":["eng"],"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"May 30, 2025"}],"relHost":[{"disp":"Impact of omitting clinical target volume in radiotherapy for locally advanced non-small cell lung cancer a propensity score matching analysisTranslational Lung Cancer Research","name":{"displayForm":["Society for Translational Cancer Research (STCR)"]},"recId":"777778599","pubHistory":["1.2012 -"],"note":["Gesehen am 03.12.2021"],"origin":[{"dateIssuedDisp":"2012-","publisherPlace":"[Erscheinungsort nicht ermittelbar]","publisher":"[Verlag nicht ermittelbar]","dateIssuedKey":"2012"}],"id":{"zdb":["2754335-3"],"issn":["2226-4477"],"eki":["777778599"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"titleAlt":[{"title":"Transl Lung Cancer Res"},{"title":"TLCR"}],"title":[{"title_sort":"Translational Lung Cancer Research","subtitle":"TLCR","title":"Translational Lung Cancer Research"}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"year":"2025","extent":"16","issue":"5","volume":"14","pages":"1770-1785","text":"14(2025), 5 vom: Mai, Seite 1770-1785"}}],"title":[{"title_sort":"Impact of omitting clinical target volume in radiotherapy for locally advanced non-small cell lung cancer","subtitle":"a propensity score matching analysis","title":"Impact of omitting clinical target volume in radiotherapy for locally advanced non-small cell lung cancer"}],"person":[{"role":"aut","given":"Liang","family":"Liu","display":"Liu, Liang"},{"role":"aut","family":"Bao","display":"Bao, Wen","given":"Wen"},{"role":"aut","family":"Yuan","display":"Yuan, Xiaoshuai","given":"Xiaoshuai"},{"role":"aut","given":"Yaoyao","family":"Zhu","display":"Zhu, Yaoyao"},{"given":"Ying","family":"Zhang","display":"Zhang, Ying","role":"aut"},{"role":"aut","display":"Christopoulos, Petros","family":"Christopoulos","given":"Petros"},{"display":"Abbar, Baptiste","family":"Abbar","given":"Baptiste","role":"aut"},{"display":"Qian, Cheng","family":"Qian","given":"Cheng","role":"aut"},{"role":"aut","given":"Shuangyan","family":"Yang","display":"Yang, Shuangyan"},{"role":"aut","given":"Yaping","family":"Xu","display":"Xu, Yaping"}],"physDesc":[{"extent":"16 S.","noteIll":"Illustrationen"}],"note":["Online erschienen: 28.05.2025","Gesehen am 01.12.2025"],"recId":"1943020205","name":{"displayForm":["Liang Liu, Wen Bao, Xiaoshuai Yuan, Yaoyao Zhu, Ying Zhang, Petros Christopoulos, Baptiste Abbar, Cheng Qian, Shuangyan Yang, Yaping Xu"]}} 
SRT |a LIULIANGBAIMPACTOFOM3020